Jun 2026 (Q2 FY26) — Aug 6, 2026
Health Catalyst Q2 FY26 — Vitalware Divestiture and Debt Repayment Drive Strategic Focus
Read the full callHealth Catalyst (HCAT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Health Catalyst earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 70.5 | −12.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -51.8 | −5.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -40.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$1.71 −1.16% · −$0.02
Performance −43.9% 1Y
1Y: $3.05 on 17 Oct 2025 → $1.71. High $3.46 (27 Oct 2025), low $1 (10 Apr 2026).
- Previous close
- $1.73
- 52-week range
- $1 – $3.46
- One year
- −45.19%
Overview
- Symbol
- HCAT
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Health Catalyst earnings calls (HCAT)
Financials
What the filings say
Net profit, year on year: +1% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 76 | 80 | 79 | 81 | 76 | 75 | 71 | 70 |
| Operating profit | -14 | -17 | -20 | -37 | -18 | -86 | -106 | -36 |
| Operating margin | −17.9% | −22.0% | −25.4% | −46.0% | −22.9% | −115.3% | −150.5% | −51.8% |
| Net profit | -15 | -21 | -24 | -41 | -22 | -91 | -111 | -41 |
| EPS ($ per share) | -0.24 | — | -0.35 | -0.59 | -0.32 | — | -1.53 | -0.55 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 1,401 | 1,425 | 1,484 | 1,553 | 1,609 |
| Reserves | -375 | -611 | -726 | -879 | -999 | -1,117 | -1,187 | -1,365 |
| Total liabilities | 76 | 102 | 302 | 310 | 327 | 335 | 494 | 257 |
| Fixed assets | 5 | 4 | 13 | 23 | 26 | 26 | 29 | 34 |
| Investments | 5 | 210 | 179 | 252 | 247 | 211 | 142 | 45 |
| Total assets | 111 | 302 | 578 | 832 | 752 | 702 | 859 | 503 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -40 | -32 | -26 | -23 | -35 | -33 | 15 | 1 |
| Cash from investing | 21 | -210 | -83 | -140 | -39 | 20 | -23 | 36 |
| Cash from financing | 24 | 231 | 183 | 264 | -3 | 3 | 152 | -236 |
| Net cash flow | 5 | -10 | 74 | 101 | -77 | -10 | 143 | -199 |
| Capital expenditure | -2 | -2 | -8 | -10 | -2 | -1 | -2 | -1 |
| Free cash flow | -42 | -34 | -34 | -34 | -37 | -34 | 13 | -0 |
Insider filings
49 filings between Dec 1, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$105.4K
1 purchase by 1 insider
Sales
$200.7K
2 sales by 2 insiders
50% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 22
- Award — granted as compensation
- 24
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Larson-Green Julie | — | $128.3K | Dec 4, 2025 |
| Kohl Simeon | $105.4K | — | Sep 14, 2026 |
| Landry Benjamin | — | $72.3K | Dec 5, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Reller Tami Director | Award | 128,851 | $0 |
| Sep 14, 2026 | Kohl Simeon Chief Executive Officer | Award | 2,747,385 | $0 |
| Sep 14, 2026 | Kohl Simeon Chief Executive Officer | Purchase | 59,000 | $105.4K |
| Sep 10, 2026 | Albert Benjamin CEO | Tax withheld | 35,244 | $59.0K |
| Sep 1, 2026 | Larson-Green Julie Director | Award | 9,766 | $0 |
| Sep 1, 2026 | Albert Benjamin CEO | Tax withheld | 321 | $547 |
| Sep 1, 2026 | Landry Benjamin General Counsel | Tax withheld | 13,167 | $22.4K |
| Sep 1, 2026 | Alger Jason Chief Financial Officer | Tax withheld | 17,973 | $30.6K |
| Jul 16, 2026 | Nelson Steven H Director | Award | 80,691 | $0 |
| Jul 16, 2026 | Spencer Justin Director | Award | 80,691 | $0 |
| Jul 16, 2026 | Hoggard Green Jill Director | Award | 80,691 | $0 |
| Jul 16, 2026 | Larson-Green Julie Director | Award | 80,691 | $0 |
| Jun 10, 2026 | Albert Benjamin CEO | Tax withheld | 34,485 | $58.3K |
| Jun 1, 2026 | Llewelyn Linda Chief People Officer | Tax withheld | 8,519 | $11.7K |
| Jun 1, 2026 | Albert Benjamin CEO | Tax withheld | 336 | $460 |
| Jun 1, 2026 | Landry Benjamin General Counsel | Tax withheld | 13,779 | $18.9K |
| Jun 1, 2026 | Alger Jason Chief Financial Officer | Tax withheld | 18,804 | $25.8K |
| Jun 1, 2026 | Larson-Green Julie Director | Award | 12,710 | $0 |
| May 1, 2026 | Nelson Steven H Director | Award | 154,808 | $0 |
| May 1, 2026 | Albert Benjamin CEO | Tax withheld | 310 | $417 |
| Apr 29, 2026 | Albert Benjamin CEO | Award | 1,124 | $0 |
| Mar 10, 2026 | Albert Benjamin CEO | Tax withheld | 70,455 | $130.2K |
| Mar 2, 2026 | Llewelyn Linda Chief People Officer | Tax withheld | 13,836 | $23.0K |
| Mar 2, 2026 | Albert Benjamin CEO | Tax withheld | 4,966 | $8.2K |
| Mar 2, 2026 | Landry Benjamin General Counsel | Tax withheld | 20,838 | $34.6K |
| Mar 2, 2026 | Alger Jason Chief Financial Officer | Tax withheld | 26,970 | $44.8K |
| Mar 1, 2026 | Larson-Green Julie Director | Award | 8,361 | $0 |
| Feb 26, 2026 | Landry Benjamin General Counsel | Tax withheld | 6,317 | $11.0K |
| Feb 26, 2026 | Alger Jason Chief Financial Officer | Tax withheld | 7,522 | $13.1K |
| Feb 26, 2026 | Llewelyn Linda Chief People Officer | Tax withheld | 4,471 | $7.8K |
| Feb 26, 2026 | Albert Benjamin CEO | Tax withheld | 13,304 | $23.3K |
| Feb 25, 2026 | Albert Benjamin CEO | Award | 38,833 | $0 |
| Feb 25, 2026 | Albert Benjamin CEO | Award | 930,000 | $0 |
| Feb 25, 2026 | Landry Benjamin General Counsel | Award | 16,473 | $0 |
| Feb 25, 2026 | Landry Benjamin General Counsel | Award | 289,000 | $0 |
| Feb 25, 2026 | Alger Jason Chief Financial Officer | Award | 507,500 | $0 |
| Feb 25, 2026 | Alger Jason Chief Financial Officer | Award | 22,222 | $0 |
| Feb 25, 2026 | Llewelyn Linda Chief People Officer | Award | 13,195 | $0 |
| Feb 25, 2026 | Llewelyn Linda Chief People Officer | Award | 191,500 | $0 |
| Feb 17, 2026 | Gallagher Duncan Director | Award | 7,562 | $0 |
| Dec 5, 2025 | Landry Benjamin General Counsel | Sale 10b5-1 plan | 27,425 | $72.3K |
| Dec 4, 2025 | Larson-Green Julie Director | Sale | 47,997 | $128.3K |
| Dec 1, 2025 | Llewelyn Linda Chief People Officer | Tax withheld | 9,762 | $28.3K |
| Dec 1, 2025 | Gallagher Duncan Director | Award | 6,209 | $0 |
| Dec 1, 2025 | Landry Benjamin General Counsel | Tax withheld | 14,387 | $41.7K |
| Dec 1, 2025 | Freeman Kevin Lee Chief Commercial Officer | Tax withheld | 16,401 | $47.6K |
| Dec 1, 2025 | Alger Jason Chief Financial Officer | Tax withheld | 20,619 | $59.8K |
| Dec 1, 2025 | Larson-Green Julie Director | Award | 5,731 | $0 |
| Dec 1, 2025 | Burton Daniel D. Chief Executive Officer | Tax withheld | 55,715 | $161.6K |
| Sep 24, 2025 | Albert Benjamin President and COO | Award | 467,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Health Catalyst, Inc.
Free account. Everything above stays public.
Write why you follow Health Catalyst, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading